Role of Cyclin-Dependent Kinase 4/6 in Metastatic Breast Cancer: Real-World Data From a Tertiary Care Institute in Eastern India.

Cureus · 2024 · PMC10859150 · PMID 38344632

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The MONARCH-3 trial showed a trend towards longer OS by adding abemaciclib to an AI (67 months versus 55 months, HR 0.75, 95% CI: 0.58-0.97) [ 21 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.